Intervention

LCAR-AIO T cells

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions5

Lead sponsors shown1

Clinical trials

2 shown

A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus ErythematosusNCT06653556 · 2025-01-08

A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune DiseasesNCT06869278 · 2025-06-17

Common conditions

Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)1 Multiple Sclerosis (MS)1 Myasthenia Gravis1 Neuromyelitis Optica Spectrum Disease (NMOSD)1 Systemic Lupus Erythematosus (SLE)1

Leading sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2

Trial status mix

RECRUITING1

WITHDRAWN1

Phase mix

EARLY_PHASE11

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.